AIRLINK 189.64 Decreased By ▼ -7.01 (-3.56%)
BOP 10.09 Decreased By ▼ -0.05 (-0.49%)
CNERGY 6.68 Decreased By ▼ -0.01 (-0.15%)
FCCL 34.14 Increased By ▲ 1.12 (3.39%)
FFL 17.09 Increased By ▲ 0.44 (2.64%)
FLYNG 23.83 Increased By ▲ 1.38 (6.15%)
HUBC 126.05 Decreased By ▼ -1.24 (-0.97%)
HUMNL 13.79 Decreased By ▼ -0.11 (-0.79%)
KEL 4.77 Increased By ▲ 0.01 (0.21%)
KOSM 6.58 Increased By ▲ 0.21 (3.3%)
MLCF 43.28 Increased By ▲ 1.06 (2.51%)
OGDC 224.96 Increased By ▲ 11.93 (5.6%)
PACE 7.38 Increased By ▲ 0.37 (5.28%)
PAEL 41.74 Increased By ▲ 0.87 (2.13%)
PIAHCLA 17.19 Increased By ▲ 0.37 (2.2%)
PIBTL 8.41 Increased By ▲ 0.12 (1.45%)
POWER 9.05 Increased By ▲ 0.23 (2.61%)
PPL 193.09 Increased By ▲ 9.52 (5.19%)
PRL 37.34 Decreased By ▼ -0.93 (-2.43%)
PTC 24.02 Decreased By ▼ -0.05 (-0.21%)
SEARL 94.54 Decreased By ▼ -0.57 (-0.6%)
SILK 0.99 Decreased By ▼ -0.01 (-1%)
SSGC 39.93 Decreased By ▼ -0.38 (-0.94%)
SYM 17.77 Decreased By ▼ -0.44 (-2.42%)
TELE 8.66 Decreased By ▼ -0.07 (-0.8%)
TPLP 12.39 Increased By ▲ 0.18 (1.47%)
TRG 62.65 Decreased By ▼ -1.71 (-2.66%)
WAVESAPP 10.28 Decreased By ▼ -0.16 (-1.53%)
WTL 1.75 Decreased By ▼ -0.04 (-2.23%)
YOUW 3.97 Decreased By ▼ -0.03 (-0.75%)
BR100 11,814 Increased By 90.4 (0.77%)
BR30 36,234 Increased By 874.6 (2.47%)
KSE100 113,247 Increased By 609 (0.54%)
KSE30 35,712 Increased By 253.6 (0.72%)

"Multiple Sclerosis (MS) is one of the most common neurological disorders and causes of disability in young adults," according to a 2008 WHO publication. Although some people with MS lead functional lives without acute disability, 60 percent of people with MS become incapable of walking only 20 years after the first onset of the disease, severely diminishing their quality of life.
Women are two to three times more likely to develop the disease than men, according to the National Multiple Sclerosis Society, US. Though the cause of this often-devastating illness is still largely unknown, new treatments are now available to manage the disease. To shed more lights on the issues related to MS, Aga Khan University Hospital (AKUH) hosted a public awareness programme highlighting treatments, symptoms and effects of MS in Pakistan.
MS is thought to be an autoimmune disease where the bodys defence system attacks the fatty tissue surrounding the nerves, brain and spinal cord. It has different symptoms ranging from numbness in the limbs to paralysis and double vision, all of which are caused when damage to this fatty tissue interferes with signals transmitted around the body through the nervous system.
Dr Mughis Sheerani, Consultant Neurologist, AKUH, said: "It is important that physicians in Pakistan recognise the early symptoms of MS so it is properly diagnosed and its progression controlled." He also added that an MRI scan of the brain with contrast was the gold standard test to confirm MS.
Patients who have MS usually suffer from multiple attacks that cause more damage as the disease progresses. "While no cure exists for the disease, there are new cutting edge treatments available to combat the progression of the disease," said Dr Mohammad Wasay, Consultant Neurologist, AKUH.
A database of MS patients has been set up at AKU, where two studies related to the genetic factors and progression of MS among Pakistani patients are underway. Research shows that new treatments modify how the disease progresses and helps tackle relapses and manage symptoms, allowing patients to live more comfortably with the disease.
To better equip patients to cope with the physical effect of the disease, Asim Mehmood, Physiotherapist, AKUH, spoke about various rehabilitation options open to patients and their families, including physical, occupational and speech therapy, among others.-PR

Copyright Business Recorder, 2009

Comments

Comments are closed.